Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

2seventy bio Stock News

TSVTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

2seventy bio (TSVT) Forecast

News

Earnings 2seventy bio (TSVT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest 2seventy bio Stock News | NASDAQ:TSVT | Benzinga

Get the latest news on 2seventy bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on 2seventy bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, March 25, 2025

2seventy bio Q4 2024 GAAP EPS $(0.37) Misses ...
Benzinga Newsdesk - Mar 25, 2025, 4:11PM

Friday, March 14, 2025

Morgan Stanley Maintains Equal-Weight on 2sev...
Benzinga Newsdesk - Mar 14, 2025, 8:19AM

Tuesday, March 11, 2025

Crude Oil Gains 1%; Ciena Earnings Top Views
Avi Kapoor - Mar 11, 2025, 12:02PM
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Vandana Singh - Mar 11, 2025, 10:17AM
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
Avi Kapoor - Mar 11, 2025, 9:56AM
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor - Mar 11, 2025, 9:14AM
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
Avi Kapoor - Mar 11, 2025, 8:55AM
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk - Mar 11, 2025, 8:34AM
Leerink Partners Downgrades 2seventy bio to M...
Benzinga Newsdesk - Mar 11, 2025, 8:20AM
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Mar 11, 2025, 6:55AM
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'
Rishabh Mishra - Mar 11, 2025, 6:52AM
Reported Earlier, 2seventy bio Agrees To Be A...
Benzinga Newsdesk - Mar 11, 2025, 1:41AM

Friday, February 07, 2025

Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
Vandana Singh - Feb 7, 2025, 7:50AM

Thursday, February 06, 2025

2Seventy Bio Reports Preliminary Full-year U....
Benzinga Newsdesk - Feb 6, 2025, 7:13AM

Tuesday, November 12, 2024

2seventy bio Q3 2024 GAAP EPS $(0.19) Beats $...
Benzinga Newsdesk - Nov 12, 2024, 7:02AM
Earnings Scheduled For November 12, 2024
Benzinga Insights - Nov 12, 2024, 3:32AM

Monday, November 11, 2024

2seventy bio Earnings Preview
Benzinga Insights - Nov 11, 2024, 9:02AM

Friday, October 18, 2024

Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
Vandana Singh - Oct 18, 2024, 1:21PM

Thursday, October 03, 2024

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Oct 3, 2024, 4:31PM

Wednesday, September 25, 2024

Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
Vandana Singh - Sep 25, 2024, 11:56AM
2seventy Expects Q3 Abecma US Revenue Growth ...
Benzinga Newsdesk - Sep 25, 2024, 6:05AM
2seventy bio Anticipate KarMMa-9 Study Study ...
Benzinga Newsdesk - Sep 25, 2024, 6:04AM
2seventy bio, Bristol Myers Squibb Discontinu...
Benzinga Newsdesk - Sep 25, 2024, 6:03AM

Wednesday, August 07, 2024

2seventy Bio shares are trading higher after ...
Benzinga Newsdesk - Aug 7, 2024, 1:51PM
2seventy bio Q2 2024 Adj. EPS $(0.29) Beats $...
Benzinga Newsdesk - Aug 7, 2024, 7:45AM

Monday, July 29, 2024

Morgan Stanley Maintains Equal-Weight on 2sev...
Benzinga Newsdesk - Jul 29, 2024, 12:30PM

Thursday, June 27, 2024

Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
Vandana Singh - Jun 27, 2024, 1:17PM
Wedbush Reiterates Neutral on 2seventy bio, M...
Benzinga Newsdesk - Jun 27, 2024, 9:41AM

Wednesday, June 26, 2024

2seventy Bio shares are trading higher after ...
Benzinga Newsdesk - Jun 26, 2024, 4:12PM
2seventy Bio Sells Hemophilia A Candidate And...
Benzinga Newsdesk - Jun 26, 2024, 4:12PM

Thursday, May 09, 2024

Canaccord Genuity Maintains Buy on 2seventy b...
Benzinga Newsdesk - May 9, 2024, 3:08PM

Wednesday, May 08, 2024

2seventy bio Q1 Adj $(0.81), Inline, Sales $1...
Benzinga Newsdesk - May 8, 2024, 7:08AM

Friday, April 19, 2024

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Vandana Singh - Apr 19, 2024, 9:28AM

Tuesday, April 09, 2024

2Seventy Bio Said Co, Bristol Myers Squibb An...
Charles Gross - Apr 9, 2024, 7:06AM

Monday, April 08, 2024

Citigroup Maintains Buy on 2seventy bio, Rais...
Benzinga Newsdesk - Apr 8, 2024, 6:12PM

Friday, April 05, 2024

FDA Approves Bristol-Myers/2seventy Bio's Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer
Vandana Singh - Apr 5, 2024, 1:37PM
At An Estimated Median Duration Of Follow-Up ...
Benzinga Newsdesk - Apr 5, 2024, 9:09AM
U.S. FDA Approves Bristol Myers Squibb And 2s...
Benzinga Newsdesk - Apr 5, 2024, 9:07AM

Wednesday, March 20, 2024

2seventy bio Adds Eli Casdin And Charles Newt...
Benzinga Newsdesk - Mar 20, 2024, 5:12PM

Monday, March 18, 2024

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor - Mar 18, 2024, 2:37PM
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Vandana Singh - Mar 18, 2024, 10:16AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Mar 18, 2024, 9:05AM
Market-Moving News for March 18th
Benzinga Newsdesk - Mar 18, 2024, 8:44AM
Wedbush Reiterates Neutral on 2seventy bio, M...
Benzinga Newsdesk - Mar 18, 2024, 8:39AM
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Mar 18, 2024, 8:06AM
2seventy Bio shares are trading higher after ...
Benzinga Newsdesk - Mar 18, 2024, 7:35AM
Reported Saturday, FDA Advisory Committee Vot...
Benzinga Newsdesk - Mar 18, 2024, 2:37AM

Friday, March 15, 2024

Trading Halt: Halt status updated at 6:55:00 ...
Benzinga Newsdesk - Mar 15, 2024, 6:55PM
Trading Halt: Halted at 1:00:00 p.m. ET - Tra...
Benzinga Newsdesk - Mar 15, 2024, 1:00PM
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Mar 15, 2024, 8:13AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved